Hermes Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Hermes Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$118M	Buy	571,922 +36,594	+7%	+$7.77M	1.57%	7
2018 Q1	$111M	Sell	535,328 -85,149	-14%	-$17.9M	1.61%	6
2017 Q4	$118M	Buy	620,477 +15,488	+3%	+$2.97M	1.69%	6
2017 Q3	$114M	Buy	604,989 +55,912	+10%	+$10.1M	1.72%	5
2017 Q2	$95.8M	Sell	549,077 -82,052	-13%	-$13.8M	1.56%	7
2017 Q1	$96.9M	Buy	631,129 +36,367	+6%	+$5.56M	1.57%	6
2016 Q4	$83.9M	Buy	594,762 +141,651	+31%	+$20.9M	1.43%	9
2016 Q3	$72.1M	Buy	453,111 +136,274	+43%	+$21M	1.22%	17
2016 Q2	$46.8M	Buy	316,837 +28,900	+10%	+$4.27M	0.94%	29
2016 Q1	$41.1M	Buy	287,937 +4,160	+1%	+$558K	0.86%	32
2015 Q4	$40.3M	Buy	283,777 +10,963	+4%	+$1.46M	0.91%	33
2015 Q3	$33.4M	Sell	272,814 -179,371	-40%	-$23.4M	0.86%	40
2015 Q2	$58.7M	Hold	452,185	–	–	1.32%	12
2015 Q1	$60.7M	Buy	452,185 +5,600	+1%	+$722K	1.41%	10
2014 Q4	$56M	Buy	446,585 +1,005	+0.2%	+$122K	1.44%	14
2014 Q3	$54.2M	Buy	445,580 +94,390	+27%	+$11.5M	1.39%	12
2014 Q2	$41.4M	Buy	351,190 +325,772	+1,282%	+$38.3M	1.15%	20
2014 Q1	$3.06M	Buy	25,418 +890	+4%	+$106K	0.1%	109
2013 Q4	$2.73M	Hold	24,528	–	–	0.08%	106
2013 Q3	$2.26M	Hold	24,528	–	–	0.08%	110
2013 Q2	$2.08M	Buy	+24,528	New	+$2.04M	0.08%	124

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hermes Investment Management's TMO Position: Q2 2018 in Review

Hermes Investment Management increased its Thermo Fisher Scientific (TMO) stake by 6.8% in Q2 2018, buying an estimated $7.77M and bringing the position to 571,922 shares worth $118M. The position accounts for 1.57% of the portfolio, ranked #7.

Hermes Investment Management first reported a position in TMO in Q2 2013 and has held it in 21 quarters since. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

Hermes Investment Management held 571,922 shares of Thermo Fisher Scientific worth $118M as of Q2 2018.
Hermes Investment Management bought 36,594 Thermo Fisher Scientific shares in Q2 2018, an estimated $7.77M.
Thermo Fisher Scientific made up 1.57% of Hermes Investment Management's portfolio in Q2 2018, its #7 holding.
Hermes Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 21 quarters since.
1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.